Skip to main content

Table 2 Frequencies of IL-10 Promoter Alleles and Genotype/Haplotypes in Patients With HBV and healthy Control Population

From: Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa

 

patients (%)

control (%)

OR

P

Allele

n = 52 × 2

n = 48 × 2

  

   - 1082G

4(3.9)

3(3.1)

1.24

0.99

   - 1082A

100(98)

93(96.8)

0.81

0.99

   - 819C

18(17.3)

18(18.7)

0.91

0.85

   - 819T

86(92.7)

78(81.3)

1.97

0.85

 

38(36.5)

22(22.9)

1.88

0.05

   - 592A

66(63.4)

74(77.1)

0.52

0.05

Genotype

n = 52

n = 48

  

   - 592 A/A

23 (44.2)

30 (62.5)

0.48

0.08

A/C

20(38.4)

14(29.2)

1.52

0.40

C/C

9(17.3)

4(8.3)

2.3

0.24

   - 819T/T

36(69.2)

33(68.8)

1.02

0.99

T/C

12(23.1)

12(23.1)

0.9

0.99

C/C

4(7.7)

4(7.7)

1.25

0.99

   - 1082 A/A

48(92.3)

45(93.8)

0.8

0.99

A/G

4(7.7)

3(6.3)

1.25

0.99

G/G

0(0)

0(0)

  

   Heplotype(-1082/-819/-592)

   
 

n = 52

n = 48

  

GCC

4 (7.6)

3(6.2)

1.25

0.99

ACC

13 (25)

14(29.1)

0.81

0.66

ATA

41 (78.8)

43(89.5)

0.43

0.18

GTA

2 (3.8)

2(4.1)

0.92

0.99

  1. NOTE: n is the number of patients or controllers. P values were caculated by Fisher Probability. P values less than 0.05 were considered statistically significant. SR: sustained response; NR: non-responders.